FMN has been shown to alleviate ovarian cancer in SKOV-3 cells by increasing E-cadherin expression and decreasing MMP-9 expression, which inhibits the cancer cell proliferation, migration, and invasion (Gu et al., 2020). Here, MMP9 is linked to ovarian cancer.